HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):: US40637H1095
LEI:
Country:: United States of America
Address:: 12390 EL CAMINO REAL, 92130 SAN DIEGO
Website:: https://www.halozyme.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Mare Nostrum Comprehensive HR solutions provider for recruitment, temporary work, training, and wage portage.	France	ALMAR
Marubeni Construction Material Lease Co.,Ltd. Leases and sells temporary steel materials and offers engineering for major construction projects.	Japan	9763
MATCHING SERVICE JAPAN CO.,LTD. Specialized recruitment firm connecting legal, finance, and accounting experts with top companies.	Japan	6539
Material Group inc. A professional services firm offering PR consulting, marketing, and brand strategy.	Japan	156A
Medesis Pharma S.A. Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.	France	ALMDP
MEDICINOVA INC Developing small-molecule therapies for neurological, respiratory, and fibrotic diseases.	United States of America	MNOV
Medicofarma Biotech Spolka Akcyjna A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.	Poland	MDB
Medpace Holdings, Inc. Global CRO providing full-service clinical development to biotech, pharma & medical device industries.	United States of America	MEDP
MedPacto, Inc. Develops biomarker-based precision therapies for oncology and other incurable diseases.	South Korea	235980
Medrx Co.,Ltd. Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.	Japan	4586